Our stories

The award is given to a UMass Chan medical student who has demonstrated outstanding skills in leadership, advocacy and service.

Global cancer cases have doubled since 1990. UMass Chan experts point to lifestyle, environmental and alcohol-related factors as key drivers.

Fifty-six people were inducted into the Delta chapter of the Alpha Omega Alpha Honor Medical Society on Nov. 12, including 34 members of the T.H. Chan School of Medicine Class of 2026.

Enrollment in the study will start in early 2026, with a focus on patients recently initiating GLP-1 therapies in the Worcester area.

PhD candidate Katherine Murphy received a Ruth L. Kirschstein National Research Service Award Individual Predoctoral Fellowship for her pancreatic cancer research.

Postdoc Nikita Bhalerao, PhD, received the 2025 Rising Star Award from the National Pancreas Foundation and a fellowship from the Pancreatic Cancer Alliance.

The Department of Defense trial aims to repurpose metformin for patients with idiopathic pulmonary fibrosis and build a network for pulmonary fibrosis research.

Melissa Fischer, MD, MEd, is one of just three UMass Chan recipients of the Glaser Award and the first in more than 25 years.

A new study in The Lancet confirms a rabies monoclonal antibody therapy, co-developed by UMass Chan, is a safe alternative to existing rabies immune globulins.

UMass Chan Medical School has licensed worldwide rights to a long-lasting human monoclonal antibody that prevents Lyme disease to New Jersey-based Tonix Pharmaceuticals Holding Corp.